Study Links ‘Forever Chemicals’ to Testicular Cancer in Military Personnel
Gary Flook served in the Air Force for 37 years, as a firefighter at the now-closed Chanute Air Force Base in Illinois and the former Grissom Air Force Base in Indiana, where he regularly trained with aqueous film forming foam, or AFFF — a frothy white fire retardant that is highly effective but now known to be toxic.
Flook volunteered at his local fire department, where he also used the foam, unaware of the health risks it posed. In 2000, at age 45, he received devastating news: He had testicular cancer, which would require an orchiectomy followed by chemotherapy.
Hundreds of lawsuits, including one by Flook, have been filed against companies that make firefighting products and the chemicals used in them.
And multiple studiesopens in a new tab or window show that firefighters, both military and civilian, have been diagnosed with testicular cancer at higher rates than people in most other occupations, often pointing to the presence of perfluoroalkyl and polyfluoroalkyl substances, or PFAS, in the foam.
But the link between PFAS and testicular cancer among service members was never directly proven — until now.
A new federal studyopens in a new tab or window for the first time shows a direct association between PFOS, a PFAS chemical, found in the blood of thousands of military personnel and testicular cancer.
Using banked blood drawn from Air Force servicemen, researchers at the National Cancer Institute (NCI) and Uniformed Services University of the Health Sciences (USUHS) found strong evidence that airmen who were firefighters had elevated levels of PFAS in their bloodstreams and weaker evidence for those who lived on installations with high levels of PFAS in the drinking water. And the airmen with testicular cancer had higher serum levels of PFOS than those who had not been diagnosed with cancer, said study co-author Mark Purdue, PhD, a senior investigator at NCI.
“To my knowledge,” Purdue said, “this is the first study to measure PFAS levels in the U.S. military population and to investigate associations with a cancer endpoint in this population, so that brings new evidence to the table.”
In a commentaryopens in a new tab or window in the journal Environmental Health Perspectives, Kyle Steenland, PhD, a professor at Emory University’s Rollins School of Public Health, said the research “provides a valuable contribution to the literature,” which he described as “rather sparse” in demonstrating a link between PFAS and testicular cancer.
More studies are needed, he said, “as is always the case for environmental chemicals.”
